Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
INTACT 2 (Gefitinib 500mg), 2004 | randomized controlled trial | ||||
INTACT 1 (gefitinib 500mg), 2004 | randomized controlled trial |
G. Giaccone J Clin Oncol 2004; 22:777-84-. 10.1200/JCO.2004.08.001 |